This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Feher, M. D Search for Related Content Social Bookmarking                         What's this?

Beyond LDL lowering: the role of dyslipidaemia and inflammation

Lipid Clinic and Beta Cell Diabetes Centre, Chelsea and Westminster Hospital, London, SW10 9NH, UK, michael.feher{at}chelwest.nhs.uk

References

• Elkeles RS, Diamond JR, Poulter C. et al. The SENDCAP Study Group. Cardiovascular outcomes in type 2 diabetes. Diabetes Care 1998;21: 641-8.[Abstract]
• Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001;357:905-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 3, 157-159 (2003)
DOI: 10.1177/14746514030030030101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Feher, M. D Search for Related Content Social Bookmarking                         What's this?